Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis

Oncogene

Volumn 26, Issue 30, 2007, Pages 4453-4463

  Takayama, K ^a,c   Kaneshiro, K ^b   Tsutsumi, S ^b   Horie Inoue, K ^c   Ikeda, K ^c   Urano, T ^a,c   Ijichi, N ^c   Ouchi, Y ^a   Shirahige, K ^d   Aburatani, H ^b,e   Inoue, S ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Androgen receptor; Androgen response element; Chromatin immunoprecipitation; Prostate cancer; UGT1A

Indexed keywords

ANDROGEN RECEPTOR; GLUCURONOSYLTRANSFERASE 1A1; HISTONE H3; HISTONE H4; PROTEIN; PROTEIN CDH2; PROTEIN P160; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MICROARRAY; ENHANCER REGION; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENOME ANALYSIS; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; INTRON; MALE; MICROARRAY ANALYSIS; MULTIGENE FAMILY; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RECEPTOR BINDING; REPORTER GENE; TRANSCRIPTION REGULATION; UPREGULATION; VALIDATION STUDY;

ACETYLATION; ANDROGENS; ANTIGENS, CD; BINDING SITES; CADHERINS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; GLUCURONOSYLTRANSFERASE; HISTONES; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RESPONSE ELEMENTS; RNA POLYMERASE II; TRANSCRIPTION, GENETIC;

EID: 34347324035     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210229     Document Type: Article

References (40)

1. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ et al. (2005). Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120: 169-181.
2. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ et al. (2005). Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33-43.
3. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D et al. (2004). Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116: 499-509.
4. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R et al. (2004). Molecular determinants of resistance to antiandrogen therapy. Nat Med 10: 33-39.
5. Chen S, Beaton D, Nguyen N, Senekeo-Effenberger K, Brace-Sinnokrak E, Argikar U et al. (2005). Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 280: 37547-37557.
6. Chene L, Giroud C, Desgrandchamps F, Boccon-Gibod L, Cussenot O, Berthon P et al. (2004). Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene. Int J Cancer 111: 798-804.
7. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM et al. (1984). Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311: 29-33.
8. Coutts AS, MacKenzie E, Griffith E, Black DM. (2003). TES is a novel focal adhesion protein with a role in cell spreading. J Cell Sci 116: 897-906.
9. Diaz M, Rodriguez JC, Sanchez J, Sanchez MT, Martin A, Merino AM et al. (2002). Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma. Int J Biol Markers 17: 125-129.
10. Duguay Y, McGrath M, Lepine J, Gagne JF, Hankinson SE, Colditz GA et al. (2004). The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res 64: 1202-1207.
11. ENCODE Project Consortium, EP (2004). The ENCODE (ENCyclopedia of DNA Elements) Project. Science 306: 636-640.
12. Giuliani L, Ciotti M, Stoppacciaro A, Pasquini A, Silvestri I, De Matteis A et al. (2005). UDP-glucuronosyltransferases 1A expression in human urinary bladder and colon cancer by immunohistochemistry. Oncol Rep 13: 185-191.
13. Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK et al. (2001). Thirteen UDP glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11: 357-368.
14. Grossmann ME, Huang H, Tindall DJ. (2001). Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst 93: 1687-1697.
15. Harrington WR, Sengupta S, Katzenellenbogen BS. (2006). Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. Endocrinology 147: 3843-3850.
16. Hazan RB, Kang L, Whooley BP, Borgen PI. (1997). N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4: 399-411.
17. Horie-Inoue K, Bono H, Okazaki Y, Inoue S. (2004). Identification and functional analysis of consensus androgen response elements in human prostate cancer cells. Biochem Biophys Res Commun 325: 1312-1317.
18. Horie-Inoue K, Takayama K, Bono HU, Ouchi Y, Okazaki Y, Inoue S. (2006). Identification of novel steroid target genes through the combination of bioinformatics and functional analysis of hormone response elements. Biochem Biophys Res Commun 339: 99-106.
19. Humphrey PA, Zhu X, Zarnegar R, Swanson PE, Ratliff TL, Vollmer RT et al. (1995). Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 147: 386-396.
20. Jaggi M, Nazemi T, Abrahams NA, Baker JJ, Galich A, Smith LM et al. (2006). N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 66: 193-199.
21. Katou Y, Kaneshiro K, Aburatani H, Shirahige K. (2006). Genomic approach for the understanding of dynamic aspect of chromosome behavior. Methods Enzymol 409: 389-410.
22. Kawana Y, Ichikawa T, Suzuki H, Ueda T, Komiya A, Ichikawa Y et al. (2002). Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer. Prostate 53: 60-64.
23. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM et al. (2002). The human genome browser at UCSC. Genome Res 12: 996-1006.
24. Laganière J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguère V. (2005). From the cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci USA 102: 11651-11656.
25. Lepine J, Bernard O, Plante M, Tetu B, Pelletier G, Labrie F et al. (2004). Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphosphoglucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 89: 5222-5232.
26. Maeda A, Nakashiro K, Hara S, Sasaki T, Miwa Y, Tanji N et al. (2006). Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells. Biochem Biophys Res Commun 347: 1158-1165.
27. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R et al. (2003). TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31: 374-378.
28. Monks DA, Watson NV. (2001). N-cadherin expression in motoneurons is directly regulated by androgens: a genetic mosaic analysis in rats. Brain Res 895: 73-79.
29. Ogawa H, Inouye S, Tsuji FI, Yasuda K, Umesono K. (1995). Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells. Proc Natl Acad Sci USA 92: 11899-11903.
30. Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, Chung LW. (1995). c-met Proto-oncogene expression in benign and malignant human prostate tissues. J Urol 154: 293-298.
31. Porkka KP, Helenius MA, Visakorpi T. (2002). Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate. Lab Invest 82: 1573-1582.
32. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. (2004). JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32: D91-94.
33. Shang Y, Brown M. (2002). Molecular determinants for the tissue specificity of SERMs. Science 295: 2465-2468.
34. Shang Y, Myers M, Brown M. (2002). Formation of the androgen receptor transcription complex. Mol Cell 9: 601-610.
35. Strassburg CP, Manns MP, Tukey RH. (1997). Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. Cancer Res 57: 2979-2985.
36. Sugatani J, Kojima H, Ueda A, Kakizaki S, Yoshinari K, Gong QH et al. (2001). The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33: 1232-1238.
37. Tobias ES, Hurlstone AF, MacKenzie E, McFarlane R, Black DM. (2001). The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene 20: 2844-2853.
38. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ et al. (2000). Cadherin switching in human prostate cancer progression. Cancer Res 60: 3650-3654.
39. Wang Q, Carroll JS, Brown M. (2005). Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 19: 631-642.
40. Xie W, Yeuh MF, Radominska-Pandya A, Saini SP, Negishi Y, Bottroff BS et al. (2003). Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA 100: 4150-4155.